WMSA
EIGR

Weiss Multi-Strategy Advisers’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,630
Closed -$34K – 761
2023
Q2 		$34K Sell
1,630
-172
-10% -$5.3K ﹤0.01% 614
2023
Q1 		$48K Sell
1,802
-365
-17% -$17K ﹤0.01% 598
2022
Q4 		$77K Sell
2,167
-1,166
-35% -$140K ﹤0.01% 566
2022
Q3 		$753K Sell
3,333
-1,359
-29% -$334K 0.02% 517
2022
Q2 		$887K Sell
4,692
-475
-9% -$95.7K 0.03% 495
2022
Q1 		$1.29M Sell
5,167
-1,814
-26% -$287K 0.03% 465
2021
Q4 		$1.09M Sell
6,981
-119
-2% -$23K 0.02% 463
2021
Q3 		$1.42M Buy
7,100
+200
+3% +$47.5K 0.03% 461
2021
Q2 		$1.76M Buy
6,900
+233
+3% +$58.1K 0.04% 420
2021
Q1 		$1.77M Buy
6,667
+82
+1% +$25.8K 0.04% 424
2020
Q4 		$2.43M Buy
6,585
+185
+3% +$53.1K 0.05% 388
2020
Q3 		$1.56M Buy
6,400
+233
+4% +$72.5K 0.04% 376
2020
Q2 		$1.78M Buy
6,167
+967
+19% +$285K 0.05% 350
2020
Q1 		$1.06M Buy
5,200
+200
+4% +$63.8K 0.04% 305
2019
Q4 		$2.23M Buy
5,000
+333
+7% +$118K 0.04% 413
2019
Q3 		$1.44M Buy
4,667
+334
+8% +$108K 0.03% 412
2019
Q2 		$1.38M Buy
4,333
+833
+24% +$288K 0.04% 348
2019
Q1 		$1.47M Hold
3,500
– – 0.04% 361
2018
Q4 		$1.07M Buy
3,500
+2,333
+200% +$754K 0.04% 291
2018
Q3 		$420K Buy
+1,167
New +$399K 0.01% 456
2014
Q4 		– Sell
-22
Closed -$105K – 557
2014
Q3 		$105K Buy
+22
New +$116K ﹤0.01% 505

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Weiss Multi-Strategy Advisers's EIGR Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q3 2023, closing a stake of 1,630 shares — an estimated $34K sold.

Weiss Multi-Strategy Advisers first reported a position in EIGR in Q3 2014 and held it in 21 quarters. The position peaked at $2.43M in Q4 2020. 51 funds tracked by Wall St. Rank hold EIGR as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 1,630 Eiger BioPharmaceuticals, Inc. shares in Q3 2023, an estimated $34K.
  • Weiss Multi-Strategy Advisers first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2014 and held it in 21 quarters.
  • Weiss Multi-Strategy Advisers's Eiger BioPharmaceuticals, Inc. position peaked at $2.43M in Q4 2020.
  • 51 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.